Drug Shortage Report for RIVA LEUCOVORIN
| Report ID | 106795 |
| Drug Identification Number | 02493357 |
| Brand name | RIVA LEUCOVORIN |
| Common or Proper name | Riva Leucovorin |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LEUCOVORIN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 24 |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-02-20 |
| Actual start date | 2020-02-20 |
| Estimated end date | Unknown |
| Actual end date | 2020-09-30 |
| Shortage status | Resolved |
| Updated date | 2020-12-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-12-04 | French | Compare |
| v4 | 2020-12-04 | English | Compare |
| v3 | 2020-02-21 | English | Compare |
| v2 | 2020-02-20 | French | Compare |
| v1 | 2020-02-20 | English | Compare |
Showing 1 to 5 of 5